Lamisil

Medicinal product

(Invented) name

Lamisil

Active substance (s)

Terbinafinas

Strength

250 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

D01BA02, Terbinafine

Marketing authorisation holder

UAB Limedika, Lietuva

Date of authorisation

2022-05-25

Date of renewal

Documents

1691_Lamisil_2022-05-25.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Terbinafinas	250 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
108729	94835	1094835	lizdinė plokštelė	N14		Receptinis	LT/L/22/1691/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2022-05-25	Registruotas